Computational design, synthesis and evaluation of stapled peptide-based antagonists of the CGRP receptor

[thumbnail of Schofield et al. 2026.docx]
Text
- Accepted Version
· Restricted to Repository staff only
· The Copyright of this document has not been checked yet. This may affect its availability.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Schofield, A. L., Notari, E., Rožňovcová, M. ORCID: https://orcid.org/0000-0001-6638-5511, Cox, K. W., D’Aloisio, V., Steuer, C., Michel, J., Cottrell, G. S. ORCID: https://orcid.org/0000-0001-9098-7627 and Coxon, C. R. (2026) Computational design, synthesis and evaluation of stapled peptide-based antagonists of the CGRP receptor. Journal of Medicinal Chemistry. ISSN 0022-2623 doi: 10.1021/acs.jmedchem.5c03445 (In Press)

Abstract/Summary

Hydrocarbon-stapled peptide antagonists targeting the calcitonin gene-related peptide (CGRP) receptor represent a promising strategy for migraine therapy. This study uses computational design tools and molecular dynamics simulations to develop novel stapled peptide antagonists conferring improved potency and stability compared to CGRP(8-37)-NH2. Peptides with varied staple geometries and unnatural amino acids were assessed using circular dichroism and antagonism and serum stability assays. A stapled peptide (peptide 4), containing an S5/S5 i,i+4 hydrocarbon staple at positions 12 and 16 exhibited enhanced serum stability (compared to CGRP(8-37)-NH2) and retained antagonist activity. Notably, Aib36-containing peptides (16-19) remained intact following prolonged serum stability assays, but lost receptor antagonism. While the computational predictions of helicity and receptor binding largely corresponded to experimental outcomes, this trend was inconsistent highlighting current in silico limitations. Moreover, this work advances understanding of peptide structure-stability-activity relationships and informs future peptide therapeutic development, with implications for overcoming metabolic instability in peptide-based drugs.

Altmetric Badge

Dimensions Badge

Item Type Article
URI https://centaur.reading.ac.uk/id/eprint/128662
Identification Number/DOI 10.1021/acs.jmedchem.5c03445
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
Publisher American Chemical Society
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record